Terry Lally
Value, portfolio strategy, long/short equity

HealthStream: $15 By 2015

Investment Summary

Short HealthStream (NASDAQ:HSTM) at $33.30

$15 Target Price (30X 2015 P/E, 10X 2015 EBITDA) for +55% expected return over the next 1 year timeframe.

Special Situation, US$, Equity Short Recommendation

Enterprise Value of $826m with 27.7m FD shares, $104.7m net cash.

Our HealthStream short thesis is very simple.

1) Earnings Estimates/Embedded Expectations are too high and will be coming down (Déjà vu)

2) Multiple Rerating: Momentum musical chairs game with valuation based on SAAS perception revenue multiple with revenue growth juiced by ICD 10 steroids. Momentum investors bail before they expect the music to stop. ICD 10 renewals create a 2015 revenue growth headwind which suggests significant revenue growth deceleration, the kiss of death catalyst for...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details